ONO-7475 acts both on the RAS-AXL and BCL2-RAF axis, inhibiting cells overexpressing MCL-1, improving the survival of mice transplanted with multiresistant FLT3ITDmut AML cells, compared with ABT-199 alone. Here, BCL2 is linked to acute myeloid leukemia.